Opko Health (OPK) Stock: Edging Up On US Launch

Opko Health Inc. (NASDAQ: OPK)

Opko Health was off to a very rough day in the market. After starting the day off well in the red, the stock had a lot of ground to make up. Nonetheless, we’ve watched as the stock made it’s way to the green, and it seems to be spiking further upward. Below, we’ll talk about what we’re seeing from the stock, why, and what we’ll be watching for with regard to OPK ahead.

What We’re Seeing From OPK

As mentioned above, Opko Health wasn’t off to the best of trading sessions today by any means. After starting the day off well into the red, the stock spent most of the morning struggling to make it to the green. However, as the day moves on, we’re seeing that the stock not only made it to the green, but it even seems to be climbing higher. At the moment (11:35), OPK is trading at $10.31 per share after a gain of $0.11 per share (1.06%) thus far today.

Why The Stock Is Gaining

As usual, as soon as the CNA Finance team noticed that OPK was spiking, we started digging to see what was causing the movement. It didn’t take long to uncover the news at all, and it was overwhelmingly positive.

Earlier today, Opko Health officially announced the United States launch of RAYALDEE(TM). In the announcement, the company said that the treatment will be available in pharmacies nationwide as soon as Wednesday. This, of course, is big news, as it will push RAYALDEE into a commercialized, revenue-generating treatment!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on OPK. In particular, we’ll be watching RAYALDEE sales closely. While we believe that sales will go well, we saw with MNKD what can happen when volume misses the mark. Nonetheless, we’ll be watching the news and bringing it to you as soon as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required

[Image Courtesy of Wikimedia]

Leave a Comment